Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
Completed
Conditions studied: Menopausal Women
In brief
As an ancillary study to the KEEPS study (see ClinicalTrials.gov Identifier: NCT00154180), the primary purpose is to measure effects of estrogen vs. placebo in menopausal women, on autonomic function and repolarization; both measured non-invasively via holter monitoring.
Key facts
- Study ID
- NCT00580775
- Run by
- Yale University
- People needed
- 25
- Starts
- 2005-09-01
- Expected to finish
- 2010-12-01
- Last updated by the study team
- 2015-01-22
Who can join
Age: 42 and older, up to 58. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- participant of the KEEPS parent study: ClinicalTrials.gov Identifier NCT00154180
You may not qualify if…
- non-participants of parent study
Where it is running
- Yale University School of Medicine / Yale New Haven Hospital — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.